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Abstract
Background: Maintaining proper adhesion between neighboring cells depends on the ability of cells to
mechanically respond to tension at cell-cell junctions through the actin cytoskeleton. Thus, identifying the
molecules involved in responding to cell tension would provide insight into the maintenance, regulation, and
breakdown of cell-cell junctions during various biological processes. Vinculin, an actin-binding protein that
associates with the cadherin complex, is recruited to cell-cell contacts under increased tension in a myosin II-
dependent manner. However, the precise role of vinculin at force-bearing cell-cell junctions and how myosin II
activity alters the recruitment of vinculin at quiescent cell-cell contacts have not been demonstrated.
Results: We generated vinculin knockdown cells using shRNA specific to vinculin and MDCK epithelial cells. These
vinculin-deficient MDCK cells form smaller cell clusters in a suspension than wild-type cells. In wound healing
assays, GFP-vinculin accumulated at cell-cell junctions along the wound edge while vinculin-deficient cells
displayed a slower wound closure rate compared to vinculin-expressing cells. In the presence of blebbistatin
(myosin II inhibitor), vinculin localization at quiescent cell-cell contacts was unaffected while in the presence of
jasplakinolide (F-actin stabilizer), vinculin recruitment increased in mature MDCK cell monolayers.
Conclusion: These results demonstrate that vinculin plays an active role at adherens junctions under increased
tension at cell-cell contacts where vinculin recruitment occurs in a myosin II activity-dependent manner, whereas
vinculin recruitment to the quiescent cell-cell junctions depends on F-actin stabilization.
Background
Cells experience force and, therefore, need to mechani-
cally respond to stabilize cell junctions with both neigh-
boring cells and the underlying extracellular matrix.
Cadherins are the adhesion proteins composing the
adherens junctions at cell-cell contacts while cadherin-
associated proteins and the actin cytoskeleton provide
stability and structural support between neighboring
cells. The E-cadherin complex was identified as a
mechanosensor at cell-cell contacts where applying
force on the extracellular domain of E-cadherin resulted
in vinculin-dependent cell stiffening [1]. Vinculin-depen-
dent cell stiffening was also observed at integrin junc-
tions [2,3], suggesting a similar role for vinculin at both
force-bearing cell-cell and cell-matrix junctions. Thus,
vinculin may be a key protein in generating tension at
cell-cell contacts in response to external forces from
neighboring cells.
Vinculin was originally identified as a protein asso-
ciated at the ends of actin fibers terminating at the
plasma membrane [4]. Along with F-actin [5,6], addi-
tional binding partners to vinculin at focal adhesions
include talin [7,8], paxillin [9], a-actinin [10], and phos-
pholipids [11,12]. Vinculin is composed of a head and
tail domain that is linked together by a proline-rich lin-
ker region and exists in either an open, activated state
or a closed, auto-inhibited state where the head and tail
domains interact [13-15]. In the open state, previously
hidden sites for vinculin binding partners are exposed.
Vinculin activation is achieved through interacting with
one of several vinculin binding partners [14,16-18].
The association of vinculin with integrins at focal
adhesions has been well examined, where vinculin binds
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to talin and paxillin, two integrin-binding proteins [7-9].
At focal adhesions, vinculin is involved in mechano-cou-
pling between the integrins bound to the underlying
extracellular matrix, and the actin cytoskeleton [3,19,20].
In this position, vinculin plays a major role in force-gen-
erating processes such as cell migration on a two-
dimensional surface [21] and cell invasion in a three-
dimensional matrix [22]. Vinculin regulates actomyosin
force generation in response to external cues through
the vinculin tail domain [3]. Although vinculin at focal
adhesions has been well studied, the role of vinculin at
cell-cell contacts has not.
In biochemical assays with purified proteins, a direct
interaction occurs between the vinculin head domain
and the cadherin-associated protein a-catenin [23-25],
with the vinculin binding site on a-catenin located
between aa 326-509 [14,24]. The additional vinculin
interactions with b-catenin [26,27] or myosin VI [28]
have also been reported. Interestingly, vinculin recruit-
ment to cell-cell contacts is decreased by the myosin II
inhibitor blebbistatin in some epithelial cell lines
[1,25,29], thus supporting the role of vinculin in
responding to increased tension at cell-cell contacts. An
inhibitory region for vinculin binding was identified on
a-catenin (aa 510-697) and suggested a-catenin existing
in either a closed conformation with the inhibitory
domain occluding the vinculin binding site, or in an
open conformation under increased tension with the
vinculin binding site exposed [25].
MDCK cells are the prototypical polarized epithelial
cell model, yet the interaction of vinculin with the E-
cadherin complex in MDCK cells is different from
other cell lines. This has been attributed to low tension
in MDCK cell monolayers under normal conditions
possibly due to the unique cadherin distribution of
MDCK cell-cell contacts [30], thus resulting in the
lack of zonula adherens with vinculin accumulation
that is observed in other epithelial cell lines [29]. How-
ever, vinculin accumulation increases at adherens junc-
tions lining the wound edge in the MDCK wound-
healing model, a process inhibited by blebbistatin
[25,29]. Additionally, an a-catenin antibody recogniz-
ing a sequence near the vinculin binding site was loca-
lized at the junctions along the wound edge, therefore,
indicating the availability of vinculin binding sites on
a-catenin at cell-cell contacts under increased tension
[25]. Also, in HGF-treated highly migratory MDCK
cells, increased vinculin recruitment to cell-cell con-
tacts is reversed with the inclusion of blebbistatin, sug-
gesting myosin II-dependence [1]. This indicates that
vinculin is recruited under conditions of increased ten-
sion to cell-cell contacts in a myosin II activity-depen-
dent manner. Interestingly, in the MDCK cell
monolayer with low tension cell-cell contacts, vinculin
still localizes to cell-cell contacts. Therefore, additional
factors (myosin II-independent) may be recruiting vin-
culin to sites of cell-cell contacts, but the mechanisms
by which vinculin accumulates under these conditions
remain unclear.
The aim of this study was to investigate the role of
vinculin at force-bearing adherens junctions and its
recruitment to sites of cell-cell contact. In this report,
using vinculin knockdown and GFP-vinculin expressing
cells in wound-healing assays, we demonstrate that
vinculin is required for proper wound closure and vin-
culin-deficiency results in a reduced rate of wound clo-
sure. Additionally, we show that recruitment of
vinculin to cell-cell contacts is increased with F-actin
stabilization.
Results and Discussion
Generation of vinculin-deficient cells
We generated stable cell lines of vinculin knockdown
cells using three shRNA target sequences for canine vin-
culin. For analysis of vinculin in cell-cell adhesion for-
mation, two vinculin knockdown MDCK cell lines were
chosen as these subclones represented the intermediate
(37%, KD1 from shRNA#1) and least (3%, KD2 from
shRNA#2) total vinculin level compared to wild-type
(Figure 1B and Additional File 1, Figure S1). Interest-
ingly, relative to the vinculin level in wild-type cells, the
detergent insoluble vinculin in knockdown cells were
62% for KD1 and 17% for KD2 (Figure 1A and 1B).
Thus, when vinculin level is lowered by shRNA, the
detergent soluble, cytoplasmic pool of vinculin is prefer-
entially reduced while less reduction is observed in the
detergent insoluble pool. This in turn suggests that resi-
dual vinculin is preferentially associated with the actin
cytoskeleton in knockdown cells.
To further analyze the relative distribution of vinculin,
we immuno-labeled vinculin in wild-type and vinculin
knockdown cells. The immuno-labeled vinculin localized
to the cytoplasm and focal adhesions in wild-type cells,
but significantly less in knockdown cells (Figure 1C and
1D). Preferential vinculin localization to focal adhesions
in both knockdown cells (Figure 1C and 1D), albeit less
intense than wild-type cells, is consistent with the
increased insoluble vinculin pool observed with bio-
chemical analysis (Figure 1A). In a confluent MDCK
monolayer, vinculin localized to cell-cell contacts in
both wild-type and knockdown cells (Figure 1C), but
the vinculin intensity at cell-cell contacts of knockdown
cells was much weaker (Figure 1C and 1E). While com-
parable vinculin levels were present at the focal adhe-
sions between the two knockdown cell lines (Figure 1D),
KD2 had significantly less vinculin at cell-cell contacts
compared to KD1 (Figure 1E), consistent with KD2 hav-
ing a lower level of vinculin than KD1 (Figure 1A and
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1B). Together, in vinculin knockdown cells, the residual
vinculin preferentially localized to focal adhesions and
cell-cell contacts while depleting most of the cytoplas-
mic vinculin pool.
The vinculin knockdown cells have weaker cell-cell
adhesion
Since the residual vinculin in knockdown cells accumu-
lated at cell-cell contacts, albeit much less than wild-
type cells, we tested whether the residual vinculin is suf-
ficient to support cell-cell contact formations using the
hanging drop adhesion assay. The wild-type and knock-
down cells were suspended in a media to allow cell clus-
tering and cell cluster sizes were analyzed over time.
The vinculin knockdown cells displayed small cell clus-
ters (Figure 2), suggesting that cell-cell adhesion is
weaker compared to wild-type. Comparing the two vin-
culin knockdown cell lines, both knockdown cells
formed smaller cell clusters than wild-type cells, but the
more efficient knockdown cells (KD2) had smaller cell
clusters than the less efficient knockdown cell line
(KD1) after 3 hours (Figure 2). These data suggest that
the effects of shRNA are not due to off-target silencing
or clonal variation; two different shRNA sequences were
used to generate the vinculin-deficient cell lines, yet
both cell lines exhibit the knockdown level-dependent,
reduced cell clustering, Furthermore, defective cell
aggregation observed in the vinculin knockdown cells
supports the notion that vinculin is a key contributor to
the formation of proper cell-cell adhesion.
Vinculin is required for efficient wound healing
Despite the reduced vinculin level at cell-cell contacts,
vinculin knockdown cells form a cell monolayer without
any phenotypic defects (Figure 1C). Since vinculin has
been shown to localize to force-bearing sites of wound
closing cells, we analyzed collective cell movement dur-
ing wound healing by creating a single cell-sized open-
ing in a mature monolayer. In this wound healing
model, formation and contraction of the actomyosin
purse-string surrounding the closing wound generates
tension on adherens junctions at cell-cell contacts along
Figure 1 Characterization of vinculin knock-down cells. (A)
Western blot of detergent soluble and insoluble pool of vinculin in
wild-type (WT) and vinculin knockdown (KD) cells. (B) Quantification
of total and detergent insoluble pool of vinculin in wild-type and
knockdown cells. The fraction of detergent insoluble (pellet) vinculin
pool increased in both vinculin knockdown cells. (C) Immuno-
fluorescence analysis of vinculin in wild-type and knockdown cells.
Although vinculin is depleted from the cytoplasm of knockdown
cells, the residual vinculin is present at focal adhesions (top panel)
and cell-cell contacts (bottom panel). Images were taken at basal
(top panel) and apical (bottom panel) levels. The same exposure
and laser power were used to acquire and generate the images.
Scale bar 10 μm. (D) Quantification of vinculin at focal adhesions in
wild-type and knockdown cells. Immuno-fluorescence intensities
and analysis of vinculin at focal adhesions are presented as mean ±
standard error of the mean and are compared with control (*P <
0.05). (E) Quantification of vinculin at cell-cell contacts in wild-type
and knockdown cells. Immuno-fluorescence intensities and analysis
of vinculin at cell-cell contacts are presented as mean ± standard
error of the mean and are compared with control (***P < 0.001).
Figure 2 Vinculin knock-down decreases cell-cell adhesion. (A)
Cell clustering in the hanging drop adhesion assay of wild-type
(WT) and knockdown (KD2) cells. Time in hours. Scale bar 50 μm. (B)
Quantification of clustering size of wild-type and knockdown (KD1
and KD2) cells. Error bars are standard error of the mean.
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the wound edge [29,31]. In addition, vinculin was pre-
viously observed as punctate formations at cell-cell con-
tacts along the wound edge, concurrent with increased
adherens junctions formation [29].
In the wound-healing assay, vinculin accumulated at
the wound edge in both wild-type and knockdown cells.
However, vinculin intensity in the knockdown cells was
reduced compared to the wild-type cells (Figure 3A).
MDCK cells expressing GFP-vinculin were also used in
the wound healing assay to analyze the wound-healing
rate of vinculin-expressing versus vinculin-deficient
cells. GFP-vinculin rapidly accumulated at adherens
junctions along the wound edge (Figure 3B), and the
wound rapidly closed within an hour. The GFP-vinculin
cells displayed a comparable wound-healing rate to
wild-type cells (Figure 3C). In comparison to wild-type
and GFP-vinculin expressing MDCK cells, the vinculin-
deficient cells had a decreased wound-healing rate and
incomplete wound closure after 1 hour (Figure 3B and
3C). The decreased wound-healing rate suggests that the
cells along the wound edge are unable to generate suffi-
cient tension through the cytoskeleton at cell-cell con-
tacts to promote wound closure, thus, supporting
vinculin as an active participant in force generation at
cell-cell contacts.
Myosin II independent vinculin accumulation at cell-cell
contacts
Vinculin localizes along the length of cell-cell contacts
in mature MDCK cell monolayers [1,25] (Figure 1).
Since blebbistatin dissociates vinculin from cell-cell con-
tacts in other epithelial cell lines, MCF7 [28] and MTD-
Figure 3 Vinculin knock-down decreases the rate of wound-healing in MDCK cells. (A) Following ablation of a single cell in a monolayer,
an F-actin purse-string formed along the wound edge with punctate vinculin accumulation at cell-cell contacts in MDCK wild-type (WT) cells.
Vinculin knock-down (KD) cells displayed decreased vinculin and F-actin accumulation along the wound edge. The same exposure and laser
power were used to acquire and generate the images. Scale bar 10 μm. (B) Time-lapse comparison of a wound-healing assay demonstrates
vinculin accumulation at cell-cell contacts along the wound edge along with wound closure for vinculin-expressing (vinculin-GFP) cells and not
in KD cells. Stably transfected KD cells are positive for a low level of GFP expression. Time in minutes. Scale bar 10 μm. (C) Comparison of the
percentage of wound-closure after 1 hr and the initial velocity of wound closure between WT (n = 8), vinculin-GFP (n = 9), KD1 (n = 7), and KD2
(n = 11) cells. Error bars are standard error of the mean.
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1A [29], vinculin localization is thought to be myosin II
activity-dependent. Unlike other cell types, however, the
vinculin distribution at cell-cell contacts in normal
MDCK cell monolayers is not affected by blebbistatin
treatment (Figure 4A), whereas the vinculin intensity at
focal adhesions is reduced (Figure 4B). This myosin II
activity-independent vinculin localization in MDCK cells
has been attributed to the lack of tension at cell-cell
contacts in normal MDCK cells [29], albeit without
direct analysis of tension.
Calyculin-A is a serine/threonine phosphatase inhibi-
tor that inhibits Myosin Light Chain (MLC) phospha-
tase. The inhibition of MLC phosphatase is thought to
induce myosin II activity by minimizing the de-phos-
phorylation of MLC, thus myosin II remains in a phos-
phorylated and active state. In the presence of calyculin-
A, numerous actin bundles formed at the basal surface
(Figure 4B), a sign of increased myosin II-dependent
contractility by calyculin A. Interestingly, the intensity
of vinculin at cell-cell contacts was unchanged (Figure
4A). This observation suggests that a mere increase in
myosin II activation does not recruit vinculin to cell-cell
contacts of MDCK cells. Although myosin II deactiva-
tion is sufficient for the vinculin dissociation from cell-
cell contacts in some cells, the vinculin recruitment to
cell-cell contacts may require additional factors.
Actin stabilization recruits vinculin to cell-cell contacts
One factor that may be involved in recruiting vinculin
to cell-cell contacts is the amount or dynamic state of
F-actin, a binding partner to which vinculin contains F-
actin binding domains [5,6]. To determine whether vin-
culin recruitment to cell-cell contacts depends on F-
actin stabilization, cells were treated with jasplakinolide.
In confluent MDCK cell monolayers, jasplakinolide
addition lowers the turnover of the actin network at
cell-cell contacts [32]. The addition of jasplakinolide
increased both the phalloidin and vinculin intensity at
cell-cell contacts (Figure 5A and 5B). At the basal sur-
face, jasplakinolide also increased vinculin recruitment
to focal adhesions and actin bundle formation (Addi-
tional file 1, Figure S2). These results suggest that F-
actin formation or stabilization is an additional factor
required for vinculin accumulation at cell-cell contacts
in MDCK cells. Interestingly, an increase in F-actin
intensity at cell-cell contacts was observed with blebbis-
tatin-treated MDCK cells (Figure 4A), yet the vinculin
level at cell-cell contacts was unaffected, suggesting that
the stabilization of F-actin, not the amount of F-actin, is
required for vinculin recruitment at cell-cell contacts.
To test whether stabilizing F-actin affects vinculin
recruitment to cell-cell contacts under tension, jasplaki-
nolide treatment was included in the MDCK wound-
healing assay. In the presence of jasplakinolide, vinculin
accumulated at cell-cell contacts along the wound edge
similarly to control (Figure 5C). Although there was no
significant difference in initial wound-healing rates
between control and jasplakinolide-treated cells, a trend
Figure 4 Myosin II activity and vinculin recruitment to cell-cell
contacts of MDCK cells. (A) Confluent MDCK cell monolayers on
collagen-coated coverslips were incubated with media containing
50 μM blebbistatin (Bleb), 10 nM calyculin-A (CA), or media alone
(Control) for 1 hr. Cells were fixed and immunostained for vinculin
or F-actin (phalloidin) at cell-cell contacts. The same exposure and
laser power were used to acquire and generate the images. Scale
bar 10 μm. Data of immuno-fluorescence intensities and analysis of
F-actin and vinculin at cell-cell contacts are presented as mean ±
standard deviation and are compared with control (n = 10, *P <
0.05, ***P < 0.001). (B) Immuno-fluorescence of vinculin and F-actin
at basal level of confluent MDCK cells. Scale bar 10 μm.
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Figure 5 Vinculin recruitment to cell-cell contacts occurs with F-actin stabilization in MDCK cells. (A) Confluent MDCK cell monolayers on
collagen-coated coverslips were incubated with media containing 200 nM jasplakinolide (Jas) or media alone (Control), fixed, and immuno-
stained for vinculin and F-actin (phalloidin) at cell-cell contacts. The same exposure and laser power were used to acquire and generate the
images. Scale bar 10 μm. (B) Data of immuno-fluorescence intensities and analysis of F-actin and vinculin at cell-cell contacts are presented as
mean ± standard deviation and are compared with control (n = 10, ***P < 0.001). (C) Single cell ablations of confluent MDCK wild-type cell
monolayers were performed following treatment with media containing 200 nM Jas, 50 μM blebbistatin (Bleb), or media alone (Control). Vinculin
and actin accumulated along the wound edge in Jas-treated and control cells, but was reduced with Bleb treatment. Scale bar 10 μm. (D)
Comparison of the initial velocity of wound-closure between control (n = 8) and Jas-treated (n = 7) cells. Error bars are standard error of the
mean.
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towards jasplakinolide decreasing initial velocity was
observed (Figure 5D). This suggests that actin stabiliza-
tion reduces the wound closure rate, and that actin
dynamics is required for efficient wound closure.
On the other hand, vinculin accumulation was either
reduced or absent along the wound edge in blebbistatin-
treated cells (Figure 5C), likely due to the lack of con-
tractile actin network. Consistent with a previous study
[29], these cells failed to close the wound, suggesting
that myosin II activity is required for wound closure.
Since jasplakinolide treatment did not change vinculin
recruitment to the wound edge, the vinculin recruitment
is solely dependent on myosin II activity. This is in con-
trast to a mature cell monolayer, where vinculin recruit-
ment requires F-actin stabilization.
Our data suggests the existence of two vinculin pools
at the sites of cell-cell adhesion: myosin II dependent
and independent pools. In MDCK cells, the myosin II
dependent pool is revealed only when cell-cell contacts
are under high tension (e.g. force-bearing contacts dur-
ing wound healing, Figure 5C), while at quiescent cell-
cell contacts, vinculin recruitment is enhanced by phar-
macologically stabilized F-actin (Figure 5A and 5B).
Note that, at quiescent cell-cell contacts, both blebbista-
tin (Figure 4A) and jasplakinolide treatments (Figure 5A
and 5B) increased F-actin intensity, but, only F-actin sta-
bilization with jasplakinolide increased vinculin recruit-
ment at cell-cell contacts, suggesting that the F-actin
level does not always correlate with the vinculin recruit-
ment. The recruitment of the contractility-dependent
vinculin pool is likely mediated by force-sensitive con-
formational change of a-catenin, which in turn exposes
a previously masked vinculin binding site [25]. Since
force-bearing sites of wound edge cells contain VASP
recruited by zyxin to promote actin polymerization [33],
vinculin may also facilitate actin dynamics, possibly
through its barbed-end nucleation activity [34], neces-
sary for the force transmission.
At quiescent cell-cell contacts, jasplakinolide-induced
actin stabilization promotes vinculin accumulation. The
actin side-binding/bundling activity of vinculin may be
important for the maintenance of stable actin network
at cell-cell contacts. A low vinculin concentration at
MDCK cell-cell contacts is consistent with unstable
actin dynamics observed at mature cell-cell contacts
[32]. The physiological mechanism of actin stabilization
remains unclear, but a-catenin dimers have been shown
to interact with actin filaments to promote actin bundle
formation [35]. Therefore, both a-catenin and vinculin
may work together to maintain the stable actin network
at mature cell-cell junctions. Furthermore, in Drosophila
embryos, two distinct actin dynamics are present to reg-
ulate cadherin mobility [36]. These two distinct vinculin
pools may be critical for the key divergence of actin
function and may be a fundamental feature of actin reg-
ulation at cell-cell contacts.
Conclusions
The major findings of this study are that vinculin is
required for both proper cell-cell adhesion and wound
closure through contraction of the actomyosin purse-
string. Additionally, vinculin recruitment to quiescent
cell-cell contacts occurs with F-actin stabilization in
MDCK cells. These results demonstrate vinculin to
actively participate in generating force at cell-cell con-
tacts and that vinculin localization at cell-cell contacts
may occur in both a myosin II activity-dependent and
independent manner.
Methods
Cell lines and reagents
MDCK GII cells were cultured in Dulbecco’s modified
Eagle’s medium (low glucose) supplemented with 10%
fetal bovine serum, penicillin, streptomycin, and kana-
mycin. MDCK cells stably expressing GFP-vinculin was
previously described [32]. Primary antibodies used were
mouse monoclonal IgGs against vinculin (clone hVIN-1,
Sigma), E-cadherin (clone 36, BD Biosciences), and
tubulin (clone DM1A, Sigma). Myosin II activity was
perturbed with 50 μM blebbistatin (Calbiochem) or 10
nM calyculin A (Calbiochem) while 200 nM jasplakino-
lide (Molecular Probes) was used to stabilize F-actin.
shRNA
Canine vinculin-specific oligonucleotide sequences
(shRNA1: 5’-TGAAGAGAGATATGCCACC-3’, sh
RNA2: 5’-AAGGCAAGATTGAGCAAGC-3’, or sh
RNA3: 5’-CAAGCTGCTTACGAACACT-3’) were
inserted into the pSUPER.gfp/neo expression vector (Oli-
goengine), and transfected into MDCK cells using Lipo-
fectamine 2000 (Invitrogen). Stable vinculin knockdown
cells were subcloned and screened for low vinculin levels
using Western blot (see an example blot in Figure S1).
The total number of subclones was 25 (shRNA1), 19
(shRNA2), and 16 (shRNA3) clones. Stable cell lines were
maintained with 100 μg/ml G418 treatment.
Microscopy and live-cell imaging
Cells were imaged in a 37°C temperature-controlled cham-
ber using a Zeiss AxioObserver equipped with a Yokogawa
spinning disk confocal system, 40× and 63× objectives, 488
and 561 nm solid-state lasers, and a Cool SNAP HQ cam-
era. The microscope system was controlled by Slidebook
software (Intelligent Imaging Innovations).
Wound-healing assay
A photo-ablation system (Intelligent Imaging Innova-
tion) was used to ablate a single cell within a cell
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monolayer. The subsequent wound area was imaged
every minute for 1 hr and the area of the wound open-
ing was quantified using ImageJ. All images were
acquired and generated using the same exposure, laser
power, and gain. Wound size measurements within the
first 10 min following cell ablation were used to analyze
the initial velocity of wound closure.
Hanging drop assay
Cells were suspended at a density of 2.5 × 105 cells/ml
medium. 25 μl of cell suspension was seeded onto glass-
bottom dishes, inverted upside-down, and incubated at
37°C. Cell suspensions were then triturated through a
pipette tip 30 times and the cluster sizes were quantified
using ImageJ.
Immuno-fluorescence and image analysis
MDCK cells were seeded onto collagen-coated cover-
slips. Cells were fixed in 3% para-formaldehyde contain-
ing 0.3% TritonX-100 for 10 min and blocked with 1%
BSA containing 0.3% TritonX-100. Following primary
antibody incubation, immuno-labeled cells were
detected with AlexaFluor 488-conjugated secondary
antibodies (Molecular Probes). Cells were counter-
stained with AlexaFluor 568-phalloidin (Molecular
Probes) to detect F-actin. Fluorescence intensities were
quantified using ImageJ. All images were acquired and
generated using the same exposure and laser power.
Fluorescence intensities were measured at cell-cell junc-
tions by obtaining selection areas specific to F-actin
staining at cell-cell contacts. The same selection areas
obtained with F-actin images were overlaid onto corre-
sponding vinculin images to obtain vinculin intensities
along the cell-cell contacts (example images shown in
Additional file 1, Figure S3).
Statistical analyses
Results comparing two groups were analyzed using a
two-tailed, unpaired Student’s t-test assuming equal var-
iance. Results comparing three groups were analyzed
using a one-way ANOVA and significance between
groups was determined using the Bonferroni correction.
Results were considered significant when P < 0.05. Data
was analyzed using Microsoft Excel.
Additional material
Additional file 1: Figure S1. Stable subclones of vinculin knockdown
cells. Western blot of wild-type (WT) and vinculin knockdown (KD) cells
using vinculin (vin) and tubulin (tub) antibodies. Three independent
shRNA sequences were used (see Methods for detail). Figure S2.
Vinculin recruitment to focal adhesions occurs with F-actin
stabilization in MDCK cells. Confluent MDCK cell monolayers on
collagen-coated coverslips were incubated with media containing 200
nM jasplakinolide (Jas) or media alone (Control), fixed, and immune-
stained for vinculin and F-actin (phalloidin) at focal adhesions. The same
exposure and laser power were used to acquire and generate the
images. Scale bar 10 μm. Figure S3. Fluorescence intensity analysis of
vinculin and actin at cell-cell contacts. Selection areas for fluorescence
intensity for analysis were generated using F-actin (phalloidin) staining at
cell-cell contacts. Selection areas were then overlaid onto vinculin images
to measure vinculin fluorescence intensities at cell-cell contacts.
List of abbreviations
GFP: green fluorescent protein; MDCK: Madin-Darby canine kidney; MLC:
myosin light chain.
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